Tencent-backed cancer detection startup Grail raises $300m in Series C

Tencent-backed Grail Inc, a US- and Hong Kong-based healthcare firm that seeks to detect cancer at its curable stage, has raised $300 million in an oversubscribed Series C financing round joined by Chinese investors, including venture capital firm Sequoia Capital China.